project id: TCGA-SKCM; case submitter id: TCGA-FS-A1ZT; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.74; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 9.0; age at index: 55; days to birth: -20284; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1950; age at diagnosis: 20284; ajcc pathologic m: M0; ajcc pathologic n: N1b; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1617.0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2025; initial weight: 140.0; oct embedded: false; preservation method: Unknown; sample id: 2812580b-d88a-4141-bc61-92a08c292c5f; sample submitter id: TCGA-FS-A1ZT-06A; portion id: be91d2d8-e3c1-4870-b126-12b9899da222; portion submitter id: TCGA-FS-A1ZT-06A-11; slide id: d7b82c68-db47-441b-88dc-b7fcd0c24d02; slide submitter id: TCGA-FS-A1ZT-06A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 7.0; percent tumor cells: 90.0; percent tumor nuclei: 85.0; section location: TOP;